Hippocampal 1H-MRSI in ecstasy users

被引:0
|
作者
Thomas Obergriesser
Gabriele Ende
Dieter F. Braus
Fritz A. Henn
机构
[1] NMR-Research,
[2] Central Institute of Mental Health,undefined
[3] P. O. Box 12 21 20,undefined
[4] 68072 Mannheim,undefined
[5] Germany,undefined
[6] E-Mail: Tom@skullslicer.zi-mannheim.de,undefined
关键词
Key words 3,4-methylenedioxymethamphetamine; Hippocampus; Nuclear magnetic resonance;
D O I
暂无
中图分类号
学科分类号
摘要
In recent years the illicit drug ecstasy (MDMA, 3,4-methylenedioxymethamphetamine) has come into widespread use among young people. Despite clear evidence for the neurotoxic potential of MDMA in animals, corresponding evidence in humans is limited to indirect findings. In an exploratory study we compared the hippocampal 1H-MRSI (magnetic resonance spectroscopic imaging) spectra of five MDMA users with those of controls with no history of substance abuse. Although 1H-MRSI is sensitive in detecting alterations in neuronal viability in association with diseases leading to neuronal degeneration, we were not able to demonstrate any differences in hippocampal 1H-MRSI between MDMA users and controls.
引用
收藏
页码:114 / 116
页数:2
相关论文
共 50 条
  • [31] Altered white and gray matter metabolism in CADASIL -: A proton MR spectroscopy and 1H-MRSI study
    Auer, DP
    Schirmer, T
    Heidenreich, JO
    Herzog, J
    Pütz, B
    Dichgans, M
    NEUROLOGY, 2001, 56 (05) : 635 - 642
  • [32] High-resolution 1H-MRSI at 9.4 T by integrating relaxation enhancement and subspace imaging
    Wang, Yizun
    Saha, Urbi
    Rubakhin, Stanislav S.
    Roy, Edward J.
    Smith, Andrew M.
    Sweedler, Jonathan V.
    Lam, Fan
    NMR IN BIOMEDICINE, 2024, 37 (10)
  • [33] Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing 1H-MRSI at 3T
    H. Vafaeyan
    S. A. Ebrahimzadeh
    N. Rahimian
    S. Karimi Alavijeh
    A. Madadi
    F. Faeghi
    M. H. Harirchian
    H. Saligheh Rad
    Australasian Physical & Engineering Sciences in Medicine, 2015, 38 : 611 - 618
  • [34] Postictal stability of proton magnetic resonance spectroscopy imaging (1H-MRSI) ratios in temporal lobe epilepsy
    Maton, B
    Londoño, A
    Sawrie, S
    Knowlton, R
    Martin, R
    Kuzniecky, R
    NEUROLOGY, 2001, 56 (02) : 251 - 253
  • [35] Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing 1H-MRSI at 3T
    Vafaeyan, H.
    Ebrahimzadeh, S. A.
    Rahimian, N.
    Alavijeh, S. Karimi
    Madadi, A.
    Faeghi, F.
    Harirchian, M. H.
    Rad, H. Saligheh
    AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2015, 38 (04) : 611 - 618
  • [36] 1H-MRSI of motor cortex and medulla in motor neuron disease:: Contrasting metabolite changes on rostrocaudal comparison
    Pioro, EP
    Majors, AW
    Mitsumoto, H
    Nelson, DR
    Ng, TC
    NEUROLOGY, 2000, 54 (07) : A254 - A254
  • [37] Preliminary evidence of hippocampal damage in chronic users of ecstasy
    den Hollander, Bjornar
    Schouw, Marieke
    Groot, Paul
    Huisman, Henk
    Caan, Matthan
    Barkhof, Frederik
    Reneman, Liesbeth
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (01): : 83 - 85
  • [38] 1D-spectral editing and 2D multispectral in vivo 1H-MRS and 1H-MRSI - Methods and applications
    Bogner, Wolfgang
    Hangel, Gilbert
    Esmaeili, Morteza
    Andronesi, Ovidiu C.
    ANALYTICAL BIOCHEMISTRY, 2017, 529 : 48 - 64
  • [39] Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma
    Wang, Michael H.
    Roa, Wilson
    Wachowicz, Keith
    Yahya, Atiyah
    Murtha, Albert
    Amanie, John
    Chainey, Jonathan
    Quon, Harvey
    Ghosh, Sunita
    Patel, Samir
    ANTICANCER RESEARCH, 2022, 42 (05) : 2665 - 2673
  • [40] Separation of Metabolites and Macromolecules for Short-TE 1H-MRSI Using Learned Component-Specific Representations
    Li, Yahang
    Wang, Zepeng
    Sun, Ruoyu
    Lam, Fan
    IEEE TRANSACTIONS ON MEDICAL IMAGING, 2021, 40 (04) : 1157 - 1167